{ "source": "next-move", "version": "0.2.0", "resourceCount": 42, "usage": { "json": "Fetch this file from the deployed site. Botpress Execute Code can filter rows; do not RAG-search this blob as one document.", "csv": "Import into a Botpress Table (one row per program). Use | -separated array columns for filters.", "knowledgeBase": "Upload public/kb/*.md (one file per program) as a Knowledge Base source for conversational search." }, "gating": { "modalityLocked": { "needleman-npic": [ "therapeutic" ], "veritascience": [ "therapeutic" ], "bms-neuro": [ "therapeutic" ], "center-drug-discovery": [ "therapeutic" ], "ninds-devices": [ "device" ] }, "contextGated": { "ecrc": [ "emergency-care" ], "siteman-sip-rda": [ "cancer" ], "trial-care": [ "multicenter-trial" ], "mhealth-research-core": [ "digital-health", "mhealth" ], "healthcare-innovation-lab": [ "clinical-workflow", "digital-health" ], "jroc": [ "industry-collaboration", "industry-sponsored-research" ] }, "contextExpand": { "digital-health": [ "digital-health", "mhealth", "clinical-workflow" ], "clinical-workflow": [ "clinical-workflow", "digital-health" ], "industry-collaboration": [ "industry-collaboration", "industry-sponsored-research", "research-contracts", "collaboration-agreements" ], "multicenter-trial": [ "multicenter-trial" ], "cancer": [ "cancer" ], "emergency-care": [ "emergency-care" ], "mhealth": [ "mhealth", "digital-health" ] } }, "resources": [ { "id": "otm-core", "type": "resource", "title": "OTM — invention disclosure, evaluation, IP and licensing", "organization": "Office of Technology Management, WashU", "url": "https://otm.wustl.edu/disclose-inventions/licensing-process/", "internality": "washu", "needs": [ "ip-licensing", "expertise-mentorship" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "research-tool" ], "states": [ "s3", "s4", "s5", "s6", "s7", "s8" ], "problemsSolved": [ "ip", "disclosure", "license", "transfer" ], "whatYouGet": "Disclosure intake, evaluation, patent/IP strategy, marketing, licensing, and commercialization support. The disclosure asks for an invention description, creators, funding, and related information.", "whyYouMightCare": "Lets you understand transfer options without deciding to become an entrepreneur. OTM evaluates WashU inventions, handles patent strategy, and files when warranted — a conversation before a talk or paper is how that process starts.", "usefulWhen": [ "Something developed in the lab may have utility outside it", "You want to preserve transfer or commercialization options", "You are choosing among protect, license, distribute, or open-release" ], "notFor": [ "need this as a required first step for every research idea", "treat this as a substitute for deciding what success looks like to you" ], "eligibility": "WashU inventions; assignment and contact depend on academic unit. OTM’s department lookup includes neuroscience-related units.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "OTM evaluates WashU inventions and, when warranted, files and manages the patents.", "A startup is not required." ], "investigatorReturns": [ "clarity on transfer options", "possible protection before public disclosure", "a path to licensing without founding" ], "nextStates": [ "s5", "s6", "s8" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://otm.wustl.edu/disclose-inventions/licensing-process/", "https://otm.wustl.edu/disclose-inventions/otm-contact-by-washu-department/" ], "contact": "otm@wustl.edu · 314-747-1700" }, { "id": "otm-inventor-companion", "type": "resource", "title": "AI companion for new inventions", "organization": "Neurotech Hub · Department of Neuroscience, WashU", "url": "https://neurotechhub.wustl.edu/an-ai-companion-for-new-inventions/", "internality": "washu", "needs": [ "ip-licensing" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "research-tool" ], "states": [ "s3", "s4", "s5" ], "problemsSolved": [ "disclosure", "ip", "transfer", "clarity" ], "whatYouGet": "A short, structured AI interview (about 10 minutes) that produces a companion brief you can attach when filing an invention disclosure in InnovateIP. The preferred agent file includes interview instructions plus a periodically refreshed snapshot of public OTM pages.", "whyYouMightCare": "Helps you clarify claims, novelty, evidence, and how the invention advances your professional goals before or while you talk with OTM — without replacing InnovateIP or OTM’s assessment.", "usefulWhen": [ "You are preparing an invention disclosure or exploring whether to disclose", "You want a clearer story for an OTM case manager", "You have a nascent idea and want structured feedback before filing" ], "notFor": [ "treat this as a substitute for filing in InnovateIP", "use a consumer AI chat that may store or train on unpublished inventions", "treat the brief as legal advice, a patent search, or OTM’s formal evaluation" ], "eligibility": "Any WashU inventor preparing disclosure context. Use only a WashU-supported AI tool approved for institutional use with confidentiality controls for unpublished inventions.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "Alpha tool from the Neurotech Hub — not an official WashU or OTM product; workflows may change.", "Use only an institutionally approved AI tool. Consumer ChatGPT and similar tools can create a public-disclosure risk.", "The official record remains the InnovateIP disclosure; attach the brief as a companion document." ], "investigatorReturns": [ "a short companion brief for OTM", "clearer invention story before disclosure", "preliminary landscape and goal-routing context" ], "nextStates": [ "s5" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-05", "sourceUrls": [ "https://neurotechhub.wustl.edu/an-ai-companion-for-new-inventions/", "https://github.com/Neurotech-Hub/WashU-OTM-Inventor-Companion" ], "contact": "otm@wustl.edu · Neurotech Hub" }, { "id": "jroc", "type": "resource", "title": "Joint Research Office for Contracts (JROC)", "organization": "Washington University in St. Louis", "url": "https://research.washu.edu/offices/jroc/", "internality": "washu", "needs": [ "expertise-mentorship" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "research-tool", "clinical-workflow" ], "states": [ "s4", "s5", "s6", "s7", "s8" ], "problemsSolved": [ "industry-sponsored-research", "research-contracts", "clinical-trial-agreements", "data-transfer", "collaboration-agreements" ], "whatYouGet": "University-wide drafting, review, negotiation, and signature of research-related agreements, including industry-supported research agreements, industry-supported clinical trials, data transfers, service agreements, collaborations, and federal/foundation contracts and subawards.", "whyYouMightCare": "Industry collaboration is a distinct path from licensing or founding. If an outside organization wants to fund, collaborate on, test, or exchange data around the work, JROC is often the contract path that makes that relationship executable.", "usefulWhen": [ "A company or outside collaborator wants to sponsor research rather than license the invention", "You need a clinical-trial, collaboration, service, data-use, or sponsored-research agreement", "The scientific partnership is clear but the institutional agreement is not" ], "notFor": [ "Patent prosecution or licensing university IP (see OTM)", "Finding an industry partner from scratch" ], "eligibility": "WashU research agreements. JROC serves principal investigators, administrators, and sponsors university-wide; the required intake path depends on agreement type.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "JROC executes research-related agreements; OTM handles patent licensing and many material-transfer/IP matters.", "This is not an industry matchmaking program." ], "investigatorReturns": [ "an executable sponsored-research or collaboration agreement", "a compliant path for industry-funded studies and data exchange", "industry collaboration without requiring a startup or license" ], "nextStates": [ "s6", "s7", "s8" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://research.washu.edu/offices/jroc/", "https://research.washu.edu/topics/contracts-subagreements/" ], "contact": "researchcontracts@wusm.wustl.edu · 314-747-5393" }, { "id": "neurotech-hub", "type": "resource", "title": "Neurotech Hub", "organization": "Washington University in St. Louis", "url": "https://neurotechhub.wustl.edu/", "internality": "washu", "needs": [ "build-test", "expertise-mentorship" ], "inventionTypes": [ "devices-diagnostics", "software-digital", "research-tools" ], "locations": [ "washu" ], "domains": [ "device", "software", "research-tool", "algorithm" ], "states": [ "s0", "s1", "s2", "s3" ], "problemsSolved": [ "prototype", "engineering", "technical-development" ], "whatYouGet": "On-demand technical services and development of new technical paradigms and tools for neuroscience.", "whyYouMightCare": "Turns a technical problem into research capability, preliminary data, prototypes, and potentially protectable inventions — before you need a commercial plan.", "usefulWhen": [ "You have an experimental or technical problem, concept, or prototype", "You need engineering help to make the first convincing test", "You want a working tool for the lab, not a company" ], "notFor": [ "A substitute for clinical or regulatory strategy", "Late-stage company financing" ], "eligibility": "Neuroscience-oriented WashU resource. Precise project prioritization and service terms are locally managed where not publicly stated.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "Bring a problem. You do not need a commercialization plan first." ], "investigatorReturns": [ "prototypes and methods", "preliminary data", "trainee technical projects" ], "nextStates": [ "s2", "s3" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://neurotechhub.wustl.edu/" ] }, { "id": "dep", "type": "resource", "title": "Domain Expert Program (DEP)", "organization": "Office of Technology Management, WashU", "url": "https://otm.wustl.edu/items/domain-expert-program-dep/", "internality": "washu", "needs": [ "expertise-mentorship", "industry-connections" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "device", "diagnostic", "software", "research-tool", "therapeutic" ], "states": [ "s3", "s4", "s5", "s6" ], "problemsSolved": [ "external-feedback", "need-validation", "de-risking" ], "whatYouGet": "Curated sector-specific industry and investor feedback, plus actionable recommendations about commercial potential and de-risking. OTM reports DEP panels have connected projects onward to resources including the Gap Fund.", "whyYouMightCare": "Can prevent the lab from spending scarce research time on development milestones that outsiders do not value. You do not need to already know the market or have a startup team.", "usefulWhen": [ "The technology works scientifically, but you do not know what evidence industry would want next", "You want external judgment without founding a company" ], "notFor": [ "use this for general business-plan tutoring (see Skandalaris Venture Development)", "use this for founder coaching (see OTM New Ventures / EIR)" ], "eligibility": "OTM-mediated selection and referral. Complete researcher-facing public eligibility criteria are unspecified.", "requiresDisclosure": true, "companyRequired": false, "funding": null, "caveats": [ "Start with OTM. Access is mediated, not a walk-in clinic." ], "investigatorReturns": [ "external validation of need", "a shorter de-risking list", "possible onward path to Gap Fund" ], "nextStates": [ "s4", "s6", "s7" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://otm.wustl.edu/items/domain-expert-program-dep/" ], "contact": "Start with OTM · otm@wustl.edu" }, { "id": "gap-fund", "type": "resource", "title": "Washington University Gap Fund", "organization": "Office of Technology Management, WashU", "url": "https://otm.wustl.edu/disclose-inventions/gap-fund/", "internality": "washu", "needs": [ "funding" ], "inventionTypes": [ "devices-diagnostics", "software-digital", "research-tools" ], "locations": [ "washu" ], "domains": [ "device", "diagnostic", "software", "research-tool" ], "states": [ "s6", "s7" ], "problemsSolved": [ "funding", "de-risking", "prototype" ], "whatYouGet": "Translational funding for promising non-drug WashU technologies. Current OTM information says commitments are made in blocks up to $55,000; technically no overall maximum is stated.", "whyYouMightCare": "Pays for work conventional academic grants may not prioritize but that can de-risk a technology. You do not need to start a company.", "usefulWhen": [ "A specific non-drug experiment, prototype, or milestone would increase transfer value", "You have a WashU technology and a concrete de-risking experiment" ], "notFor": [ "Drug development / therapeutic candidates (see Needleman)", "General unfocused research support" ], "eligibility": "WashU researcher with an appointment covered by the IP policy; non-drug technology; proof of feasibility demonstrated; technology disclosed to OTM and properly assigned to WashU; reasonable probability of adequate IP protection. Applications/consideration are available year-round, including ad hoc proposals.", "requiresDisclosure": true, "companyRequired": false, "funding": "Commitments in blocks up to $55,000 (verify current terms)", "caveats": [ "This is not a drug-development program and does not fund startup-company expenses.", "A single award commitment is up to $55,000; larger development plans may be staged through sequential awards.", "The technology must already have proof of feasibility and be disclosed/assigned to WashU before an application." ], "investigatorReturns": [ "funded development work", "validation data", "possible grant and publication leverage" ], "nextStates": [ "s7" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://otm.wustl.edu/disclose-inventions/gap-fund/" ], "contact": "OTM · otm@wustl.edu" }, { "id": "center-drug-discovery", "type": "resource", "title": "Center for Drug Discovery (CDD)", "organization": "WashU Medicine · Center for Drug Discovery", "url": "https://cdd.wustl.edu/", "internality": "washu", "needs": [ "build-test", "funding" ], "inventionTypes": [ "therapeutics" ], "locations": [ "washu" ], "domains": [ "therapeutic" ], "states": [ "s1", "s2", "s3", "s6", "s7" ], "problemsSolved": [ "drug-discovery", "high-throughput-screening", "medicinal-chemistry", "preclinical-development", "funding" ], "whatYouGet": "An integrated small-molecule drug-discovery path from lead finding through lead optimization and preclinical studies. CDD capabilities include high-throughput and virtual screening, medicinal chemistry, ADME, pharmacokinetics/pharmacodynamics, in vivo pharmacology, and safety-oriented preclinical work. CDD also operates several pilot/matching funding mechanisms.", "whyYouMightCare": "Fills the gap between a biologically interesting target and a credible therapeutic program. It can generate chemical matter and preclinical evidence before an IND-oriented program is mature enough for resources such as Needleman.", "usefulWhen": [ "A target or assay needs small-molecule hit finding or screening", "A promising hit needs medicinal chemistry, ADME, PK/PD, or in vivo optimization", "You need preliminary drug-discovery data for follow-on grants, partnering, publication, or IP" ], "notFor": [ "Non-therapeutic devices or software", "A generic wet-lab core unrelated to small-molecule discovery", "Assume every CDD funding program has the same eligibility or deadline" ], "eligibility": "CDD services are directed at WashU drug-discovery projects. The CDD Pilot Grant and Match Grant programs state WashU faculty eligibility; the Siteman QuikSTART program additionally requires Assistant Professor-or-above status and Siteman Cancer Center membership. Verify the current funding mechanism before applying.", "requiresDisclosure": false, "companyRequired": false, "funding": "CDD Pilot, Match Grant, QuikSTART and other CDD mechanisms; amounts and cycles vary. QuikSTART is $25,000 and cancer/small-molecule specific.", "caveats": [ "Funding programs have different eligibility, cost-share, and cycle requirements.", "QuikSTART is specifically for translating cancer disease biology into small-molecule therapeutics and requires Siteman membership." ], "investigatorReturns": [ "screening hits and chemical starting points", "medicinal-chemistry and preclinical data", "preliminary data for grants, publications, partnering, and IP" ], "nextStates": [ "s3", "s6", "s7" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://cdd.wustl.edu/", "https://cdd.wustl.edu/funding/pilot-grant/", "https://cdd.wustl.edu/funding/quikstart-grant/", "https://research.washu.edu/core-facilities/high-throughput-screening-center/" ], "contact": "Center for Drug Discovery · Ron Dolle / Maxene Ilagan" }, { "id": "needleman-npic", "type": "resource", "title": "Needleman Program (NPIC)", "organization": "Needleman Program for Innovation & Commercialization, WashU", "url": "https://needlemanprogram.wustl.edu/services/", "internality": "washu", "needs": [ "funding", "expertise-mentorship", "build-test" ], "inventionTypes": [ "therapeutics" ], "locations": [ "washu" ], "domains": [ "therapeutic" ], "states": [ "s5", "s6", "s7" ], "problemsSolved": [ "therapeutic-development", "funding", "ind" ], "whatYouGet": "Funding plus drug-discovery and development expertise and business mentoring. NPIC’s stated objective is to move promising therapeutic candidates toward FDA investigational-new-drug status.", "whyYouMightCare": "Provides capabilities most academic labs are not organized to execute and can preserve the PI’s focus on science. A startup is not required.", "usefulWhen": [ "A promising WashU therapeutic candidate needs work beyond normal discovery science", "The next question is developability toward IND, not another mechanistic paper" ], "notFor": [ "Generic non-therapeutic devices", "Research tools or software without a therapeutic candidate", "Very early small-molecule hit finding or lead optimization where the Center for Drug Discovery is the more natural first door" ], "eligibility": "During open windows, PIs from any WashU school or department may apply. The public page currently says applications are closed and a future RFP is planned.", "requiresDisclosure": false, "companyRequired": false, "funding": "Program funding during open RFPs (verify current call)", "caveats": [ "Applications were closed as of 2026-09-04; treat this as a future milestone until a new RFP opens." ], "investigatorReturns": [ "drug-development expertise", "milestone-driven funding", "path toward IND without founding" ], "nextStates": [ "s7", "s8" ], "status": "closed_verify", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://needlemanprogram.wustl.edu/services/", "https://needlemanprogram.wustl.edu/application-resources/", "https://needlemanprogram.wustl.edu/contact-us/" ], "contact": "npic@wustl.edu" }, { "id": "icts", "type": "resource", "title": "ICTS Research Forum + CTRFP / Just-In-Time funding", "organization": "Institute of Clinical and Translational Sciences, WashU", "url": "https://icts.wustl.edu/research-services/research-development-program/research-forum-program/", "internality": "washu", "needs": [ "funding", "expertise-mentorship" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "diagnostic", "clinical-workflow" ], "states": [ "s1", "s2", "s3", "s4", "s6", "s7" ], "problemsSolved": [ "study-design", "funding", "grants", "translational-evidence" ], "whatYouGet": "Year-round multidisciplinary project-development or grant-review roundtables (design, aims, methods, statistics, milestones, stakeholders). CTRFP currently provides up to $50,000 direct costs for one-year clinical/translational or community-engaged projects and up to $25,000 for biostatistics/epidemiology/research-design projects. JIT provides rapid core-service support for preliminary data or certain QA/QI work.", "whyYouMightCare": "Particularly valuable for turning a promising invention into rigorous translational evidence and competitive grants. No commercialization plan or company is required.", "usefulWhen": [ "You have a translational concept or grant that needs study design and critique", "Preliminary or core-services data are the immediate bottleneck" ], "notFor": [ "A company-formation program", "Unrestricted laboratory operating support" ], "eligibility": "Research Forum is available to ICTS members across career stages and partner affiliations. CTRFP PI must be an ICTS member. As of 2026-09-04 the 2026 CTRFP LOI deadline had passed; invited full applications were due September 14, 2026. JIT has separate rolling processes and limits.", "requiresDisclosure": false, "companyRequired": false, "funding": "CTRFP up to $50,000 / $25,000 by category; JIT core-service support", "caveats": [ "CTRFP is a competitive call with cycle-specific deadlines — verify current status.", "Membership is required for CTRFP." ], "investigatorReturns": [ "stronger aims and methods", "preliminary data", "grant competitiveness", "collaborators" ], "nextStates": [ "s2", "s6", "s7" ], "status": "evergreen_program_verify_current_call", "nextDeadline": "2026-09-14 (invited CTRFP applications; verify)", "lastVerified": "2026-09-06", "sourceUrls": [ "https://icts.wustl.edu/research-services/research-development-program/research-forum-program/", "https://icts.wustl.edu/funding/ctrfp-funding-program/", "https://icts.wustl.edu/funding/just-in-time-jit/" ], "contact": "icts@wustl.edu · JIT@wustl.edu" }, { "id": "center-clinical-studies", "type": "resource", "title": "Center for Clinical Studies (CCS)", "organization": "Washington University in St. Louis", "url": "https://research.washu.edu/offices/center-for-clinical-studies/", "internality": "washu", "needs": [ "build-test", "expertise-mentorship" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "clinical-workflow" ], "states": [ "s6", "s7", "s8" ], "problemsSolved": [ "clinical-study-operations", "trial-startup", "study-closeout" ], "whatYouGet": "Administrative and clinical research services spanning the clinical-study lifecycle, from initial proposal through study close-out. CCS is also the institutional home/partner for several specialized clinical-trial support services.", "whyYouMightCare": "Once the next translational milestone requires a human study, the bottleneck is often execution rather than invention strategy. CCS is a practical door into study operations without requiring a company or license path.", "usefulWhen": [ "A device, therapeutic, diagnostic, digital intervention, or workflow is moving into human research", "You need help planning or executing the operational side of a clinical study", "You are unsure which specialized clinical-study service should own the next problem" ], "notFor": [ "Patent or licensing strategy", "General laboratory prototype engineering" ], "eligibility": "WashU clinical-research resource. Specific services, pricing, and project requirements depend on the study; contact CCS for routing.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "This is clinical-research infrastructure, not product-development funding.", "Specialized needs may route onward to Regulatory Support Center, Trial-CARE, recruitment, biostatistics, or other ICTS/CCS services." ], "investigatorReturns": [ "a more executable clinical study", "operational support from proposal through close-out", "routing to specialized trial infrastructure" ], "nextStates": [ "s7", "s8" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://research.washu.edu/offices/center-for-clinical-studies/" ], "contact": "ccs@wustl.edu · 314-747-4000" }, { "id": "icts-regulatory-support", "type": "resource", "title": "ICTS Regulatory Support Center (RSC)", "organization": "Institute of Clinical and Translational Sciences, WashU", "url": "https://icts.wustl.edu/items/regulatory-support-center-rsc/", "internality": "washu", "needs": [ "expertise-mentorship", "build-test" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "clinical-workflow" ], "states": [ "s6", "s7", "s8" ], "problemsSolved": [ "regulatory", "ind", "ide", "irb", "clinical-trial" ], "whatYouGet": "Hands-on regulatory support for human-subjects studies, including protocol and consent development, IRB submissions and maintenance, FDA drug/device submissions such as IND/IDE applications, monitoring, study coordination, audits, and study close-out.", "whyYouMightCare": "Turns 'we need a regulatory plan' into concrete study and submission work. This is especially important when the next milestone depends on an FDA-regulated drug, device, or investigator-initiated clinical study.", "usefulWhen": [ "A human study needs IRB, IND/IDE, monitoring, or regulatory planning", "You need help translating a protocol into the institutional and FDA submission path", "Regulatory execution is becoming the blocker to a clinical milestone" ], "notFor": [ "Patent prosecution or technology licensing", "General FDA market strategy detached from a research study" ], "eligibility": "Designed for ICTS investigators conducting human-subjects research. Service level and project requirements vary; request support through the RSC/CCS process.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "Regulatory support does not itself substitute for required HRPO/IRB or FDA approvals.", "Some services may carry project-specific costs or coordination requirements." ], "investigatorReturns": [ "a concrete regulatory execution plan", "IND/IDE and IRB submission support", "lower operational friction for investigator-initiated trials" ], "nextStates": [ "s7", "s8" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://icts.wustl.edu/research-services/regulatory-support/", "https://icts.wustl.edu/items/regulatory-support-center-rsc/", "https://research.washu.edu/core-facilities/regulatory-support-center/" ], "contact": "reg_spt_center@wusm.wustl.edu" }, { "id": "trial-care", "type": "resource", "title": "Trial-CARE", "organization": "Center for Clinical Studies · ICTS, WashU", "url": "https://icts.wustl.edu/items/trial-care/", "internality": "washu", "needs": [ "build-test", "expertise-mentorship" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "clinical-workflow" ], "states": [ "s6", "s7", "s8" ], "problemsSolved": [ "multicenter-trial", "trial-startup", "recruitment", "single-irb" ], "whatYouGet": "Enhanced support for WashU faculty conducting investigator-initiated clinical trials, especially multi-center studies. Trial-CARE helps with startup and implementation, single-IRB and master-agreement pathways, regulatory resources, anticipated barriers, coordination, and tailored recruitment planning.", "whyYouMightCare": "A technically ready intervention can still fail to travel because a multi-site trial is hard to start and coordinate. Trial-CARE is a concrete execution resource once the next proof requires investigator-initiated clinical testing across sites.", "usefulWhen": [ "You are planning an investigator-initiated clinical trial", "A multi-center study needs startup, coordination, single-IRB, agreement, or recruitment support", "The evidence milestone is clinically clear but operationally difficult" ], "notFor": [ "A single preclinical experiment", "General commercialization or founder coaching" ], "eligibility": "Washington University faculty conducting investigator-initiated clinical trials. Trial-CARE advertises a free consultation; project support depends on trial needs.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "Best fit is investigator-initiated clinical-trial execution, particularly multi-center work." ], "investigatorReturns": [ "faster and more structured trial startup", "coordination and recruitment planning", "a path through multi-site operational barriers" ], "nextStates": [ "s7", "s8" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://icts.wustl.edu/items/trial-care/", "https://icts.wustl.edu/research-services/regulatory-support/" ], "contact": "trialcare@wustl.edu" }, { "id": "mhealth-research-core", "type": "resource", "title": "mHealth Research Core (mHRC)", "organization": "Institute of Clinical and Translational Sciences, WashU", "url": "https://icts.wustl.edu/items/mhealth-research-core/", "internality": "washu", "needs": [ "build-test", "expertise-mentorship" ], "inventionTypes": [ "software-digital", "devices-diagnostics" ], "locations": [ "washu" ], "domains": [ "software", "device", "clinical-workflow" ], "states": [ "s1", "s2", "s3", "s6", "s7" ], "problemsSolved": [ "digital-health", "mhealth", "remote-research", "part-11" ], "whatYouGet": "Consultation and implementation support for mHealth and digital-health research using smartphones, websites, sensors, wearables, remote study methods, and related technology. The core also provides guidance on topics such as remote research, technology partnerships, and FDA Part 11-regulated digital workflows.", "whyYouMightCare": "Provides a WashU-specific bridge between a digital-health idea and a fundable, executable human-research project — a gap that generic software development or clinical-study support does not fully cover.", "usefulWhen": [ "A study uses wearables, sensors, apps, web tools, telehealth, or remote data collection", "You need to design or operationalize an mHealth research workflow", "Digital tools introduce Part 11, vendor, remote-consent, or implementation questions" ], "notFor": [ "General-purpose software engineering unrelated to health research", "A substitute for OTM when software IP or licensing is the question" ], "eligibility": "WashU/ICTS-facing research resource; consult the core for project fit and service details.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "This is a research implementation core, not a software accelerator or venture program." ], "investigatorReturns": [ "a fundable digital-health study plan", "remote-study and mHealth implementation support", "clearer regulatory and vendor choices for digital research" ], "nextStates": [ "s2", "s6", "s7" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://icts.wustl.edu/items/mhealth-research-core/", "https://research.washu.edu/part-11/" ], "contact": "Katie Keenoy · keenoyk@wustl.edu" }, { "id": "hope-center", "type": "resource", "title": "Hope Center for Neurological Disorders", "organization": "Washington University in St. Louis", "url": "https://hopecenter.wustl.edu/funding-awards/pilot-projects/", "internality": "washu", "needs": [ "funding", "expertise-mentorship" ], "inventionTypes": [ "therapeutics", "devices-diagnostics", "research-tools" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "research-tool" ], "states": [ "s1", "s2", "s3", "s4" ], "problemsSolved": [ "pilot-funding", "collaborators", "neuroscience" ], "whatYouGet": "Translational neuroscience community and pilot opportunities. Current pilot eligibility requires the project PI to be a Hope Center faculty member; cycle-specific requirements change.", "whyYouMightCare": "Pilot data, collaborators, and neuroscience-specific infrastructure can strengthen papers and external grant applications. Commercialization is not required.", "usefulWhen": [ "The work addresses neurological disease", "You need collaborative pilot funding or specialized neuroscience infrastructure" ], "notFor": [ "Investigators seeking a general startup accelerator", "Projects with no neurological-disease connection" ], "eligibility": "Hope Center faculty membership required for the PI of the current pilot program; collaborator membership rules are less restrictive.", "requiresDisclosure": false, "companyRequired": false, "funding": "Pilot awards (cycle-specific; verify current call)", "caveats": [ "Confirm current membership and cycle requirements before applying." ], "investigatorReturns": [ "pilot data", "collaborators", "grant leverage" ], "nextStates": [ "s2", "s3", "s4" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://hopecenter.wustl.edu/funding-awards/pilot-projects/" ] }, { "id": "xir", "type": "resource", "title": "OTM Experts-in-Residence (XiR)", "organization": "Office of Technology Management, WashU", "url": "https://otm.wustl.edu/items/experts-in-residence/", "internality": "washu", "needs": [ "expertise-mentorship" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "device", "diagnostic", "software", "therapeutic", "research-tool" ], "states": [ "s4", "s5", "s6" ], "problemsSolved": [ "expertise", "external-feedback" ], "whatYouGet": "Access to experienced expertise within the OTM innovation network. OTM publishes XiR eligibility for participating experts; expert participation itself is invitation-only.", "whyYouMightCare": "You do not have to independently locate every expert. This is domain judgment, not a request that you become a founder.", "usefulWhen": [ "The project needs experienced external judgment rather than general business instruction", "You want to define a product, technical, or milestone question" ], "notFor": [ "Founder coaching (see EIR / New Ventures)", "Open office hours without OTM context" ], "eligibility": "Researcher-facing routing criteria are unspecified publicly; access should be treated as OTM-mediated.", "requiresDisclosure": true, "companyRequired": false, "funding": null, "caveats": [ "Start with OTM. Do not treat XiR as a walk-in mentoring pool." ], "investigatorReturns": [ "targeted expert advice", "clearer next technical or product milestone" ], "nextStates": [ "s6" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://otm.wustl.edu/items/experts-in-residence/" ], "contact": "Start with OTM · otm@wustl.edu" }, { "id": "otm-eir", "type": "resource", "title": "OTM New Ventures / Entrepreneur-in-Residence", "organization": "Office of Technology Management, WashU", "url": "https://otm.wustl.edu/disclose-inventions/new-ventures/", "internality": "washu", "needs": [ "startup-support", "expertise-mentorship" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "diagnostic", "software" ], "states": [ "s7", "s8" ], "problemsSolved": [ "startup", "founder-coaching", "business-model" ], "whatYouGet": "Founder coaching, business-case and value-proposition refinement, business-model work, and startup mentoring. The EIR program is administered through New Ventures.", "whyYouMightCare": "Faculty can explore company formation without personally having all CEO or business-development expertise. Startup intent is relevant; this is not the default path for every disclosed invention.", "usefulWhen": [ "A startup is becoming a plausible vehicle", "Scientific founders need experienced company-building help" ], "notFor": [ "Investigators who want licensing or distribution without founding", "Early ideas with no company hypothesis" ], "eligibility": "OTM states that the research team’s WashU patent must be foundational to the startup license; EIR connection is at New Ventures’ discretion.", "requiresDisclosure": true, "companyRequired": false, "funding": null, "caveats": [ "EIR placement is only for teams focused on a startup based on WashU IP; an already-incorporated company is not the stated prerequisite.", "EIR requires a patent disclosure, foundational WashU patent rights for the startup license, a pitch deck developed with New Ventures, and coachability; placement is discretionary.", "This is founder support, not general scientific mentoring." ], "investigatorReturns": [ "company-building coaching", "a clearer go/no-go on founding", "possible license path" ], "nextStates": [ "s8", "s9" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://otm.wustl.edu/disclose-inventions/new-ventures/", "https://otm.wustl.edu/items/entrepreneur-in-residence/" ], "contact": "OTM New Ventures · otm@wustl.edu" }, { "id": "skandalaris-vd", "type": "resource", "title": "Skandalaris Venture Development", "organization": "Skandalaris Center, WashU", "url": "https://skandalaris.wustl.edu/resource/venture-development/", "internality": "washu", "needs": [ "startup-support", "expertise-mentorship" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "device", "software", "research-tool", "therapeutic", "diagnostic" ], "states": [ "s4", "s6", "s7", "s8" ], "problemsSolved": [ "venture-exploration", "business-model", "pitch" ], "whatYouGet": "30-minute advising on brainstorming, business plans, financial models, pitching, and next-step guidance.", "whyYouMightCare": "An excellent low-commitment way to ask whether entrepreneurship is even sensible. No incorporation or mature startup is required.", "usefulWhen": [ "You want help thinking through an idea, model, or next entrepreneurial step", "You are exploring founding without committing to it" ], "notFor": [ "The Skandalaris Venture Competition — current rules prohibit WashU / university IP and licenses to university IP", "A substitute for OTM evaluation of a WashU invention" ], "eligibility": "WashU students, faculty, staff, and alumni; ventures may be at any stage.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "Do not confuse Venture Development advising with the Skandalaris Venture Competition.", "SVC currently excludes WashU IP — a common mis-route for faculty inventions." ], "investigatorReturns": [ "a low-stakes read on whether a company is justified", "help framing a model or pitch if you proceed" ], "nextStates": [ "s6", "s8" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://skandalaris.wustl.edu/resource/venture-development/", "https://skandalaris.wustl.edu/programs/" ], "contact": "sc@wustl.edu" }, { "id": "healthcare-innovation-lab", "type": "resource", "title": "BJC / WashU Healthcare Innovation Lab", "organization": "BJC HealthCare · WashU Medicine", "url": "https://research.washu.edu/faculty-resources/", "internality": "washu", "needs": [ "build-test", "expertise-mentorship" ], "inventionTypes": [ "software-digital", "devices-diagnostics" ], "locations": [ "washu" ], "domains": [ "software", "device", "clinical-workflow", "algorithm" ], "states": [ "s1", "s2", "s3", "s4", "s6", "s7" ], "problemsSolved": [ "care-delivery-innovation", "digital-health", "clinical-workflow", "pilot", "implementation" ], "whatYouGet": "A joint BJC HealthCare / WashU Medicine health-system innovation program that identifies, develops, pilots, and evaluates applied innovations intended to improve care delivery and population health. Publicly described work includes predictive analytics, digital point-of-care tools, remote monitoring, and other operational innovations.", "whyYouMightCare": "For inventions whose real test is whether they improve care inside a health system, a clinical operations partner can matter more than a startup accelerator. The Lab is a potential bridge from an academic or digital idea to a real-world care-delivery pilot.", "usefulWhen": [ "The innovation changes clinical workflow, care delivery, remote monitoring, or health-system operations", "You need to test practical value in a BJC/WashU care environment", "The primary question is implementation and clinical-system value rather than licensing alone" ], "notFor": [ "Assume every faculty invention is eligible for a Lab pilot", "General patent/licensing strategy or basic laboratory prototyping" ], "eligibility": "The Lab is a joint BJC/WashU health-system innovation program. Public WashU sources describe it as a faculty resource, but a standing investigator-facing intake/eligibility process is not clearly specified; contact the program before treating it as an available pilot route.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "Selection for a formal pilot is not guaranteed and public intake criteria are not clearly specified.", "Best treated as a targeted collaboration resource for care-delivery innovation, not a general-purpose core." ], "investigatorReturns": [ "health-system feedback", "real-world pilot and implementation evidence", "clinical and operational collaborators" ], "nextStates": [ "s4", "s6", "s7" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://research.washu.edu/faculty-resources/", "https://www.bjc.org/medical-professionals/center-clinical-excellence" ], "priority": "second", "purposes": [ "research", "expertise" ] }, { "id": "siteman-sip-rda", "type": "resource", "title": "Siteman Investment Program Research Development Awards (SIP RDA)", "organization": "Siteman Cancer Center, WashU", "url": "https://siteman.washu.edu/research/funding-opportunities/", "internality": "washu", "needs": [ "funding" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "research-tool" ], "states": [ "s1", "s2", "s3", "s6" ], "problemsSolved": [ "pilot-funding", "preliminary-data", "cancer" ], "whatYouGet": "Pilot funding for pioneering cancer research intended to generate data that can leverage external peer-reviewed funding. The program spans cancer discovery, diagnosis, imaging, treatment, prevention, and translational/implementation work depending on the current cycle.", "whyYouMightCare": "For cancer-related inventions or enabling technologies, the immediate need may be stronger scientific or translational evidence rather than a commercialization grant. SIP RDA is a major internal pilot-funding route for that work.", "usefulWhen": [ "The project is cancer-related and needs pilot or preliminary data", "A defined experiment could unlock an NIH/NCI application or translational next step" ], "notFor": [ "Projects with no cancer relevance", "Assume a standing open call or fixed award amount without checking the current RFA" ], "eligibility": "Siteman membership and cycle-specific eligibility apply. Current RFA terms should be checked before routing an investigator to the program.", "requiresDisclosure": false, "companyRequired": false, "funding": "Pilot funding; amount and categories are cycle-specific", "caveats": [ "This is cancer-research pilot funding, not a startup program.", "Eligibility and award categories change by cycle; verify the current RFA." ], "investigatorReturns": [ "pilot data", "external-grant leverage", "cross-disciplinary cancer collaborations" ], "nextStates": [ "s2", "s3", "s6" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://siteman.washu.edu/research/funding-opportunities/" ], "priority": "second", "purposes": [ "research", "funding" ] }, { "id": "ecrc", "type": "resource", "title": "Emergency Care Research Core (ECRC)", "organization": "Washington University in St. Louis · Department of Emergency Medicine", "url": "https://research.washu.edu/core-facilities/ecrc/", "internality": "washu", "needs": [ "build-test", "expertise-mentorship" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "diagnostic", "clinical-workflow" ], "states": [ "s6", "s7" ], "problemsSolved": [ "emergency-care", "clinical-research", "feasibility", "recruitment", "enrollment" ], "whatYouGet": "Emergency-care clinical and translational research infrastructure, including feasibility consultation plus recruitment and enrollment support for studies involving acute illness, injury, diagnostics, time-sensitive interventions, and emergency-care workflows.", "whyYouMightCare": "Emergency-department studies have operational constraints that generic clinical research support may not solve. ECRC is a specialized execution resource when the invention must be evaluated in acute or time-sensitive care.", "usefulWhen": [ "A device, diagnostic, intervention, or workflow must be studied in emergency care", "Recruitment or enrollment in acute/time-sensitive settings is a major feasibility risk" ], "notFor": [ "Clinical studies with no emergency-care component", "General commercialization strategy" ], "eligibility": "Service available to Washington University investigators. Contact the core for pricing and project-specific feasibility.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "Highly specialized; show only when emergency-care context is relevant." ], "investigatorReturns": [ "emergency-care feasibility", "patient recruitment/enrollment support", "more executable acute-care studies" ], "nextStates": [ "s7" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://research.washu.edu/core-facilities/ecrc/" ], "priority": "second", "purposes": [ "research", "expertise" ] }, { "id": "biogenerator", "type": "resource", "title": "BioGenerator Ventures", "organization": "BioSTL", "url": "https://www.biostl.org/what-we-do/biogenerator", "internality": "regional", "needs": [ "startup-support", "funding" ], "inventionTypes": [ "therapeutics", "devices-diagnostics", "research-tools" ], "locations": [ "st-louis" ], "domains": [ "therapeutic", "device", "diagnostic", "research-tool" ], "states": [ "s7", "s8", "s9" ], "problemsSolved": [ "startup", "capital", "lab-space", "operators" ], "whatYouGet": "Early-stage capital, expert guidance, laboratory space, and hands-on company support in human health and agriculture.", "whyYouMightCare": "A strong regional bridge from university invention to an investable company and external talent. A first conversation can precede a mature fundraising round.", "usefulWhen": [ "A bioscience opportunity is becoming a company", "Founders need investment, operators, space, or investor connections" ], "notFor": [ "Academic projects with no company hypothesis", "A general faculty grant program" ], "eligibility": "Focus on high-growth science-based companies. Exact investment criteria and terms are deal-specific.", "requiresDisclosure": false, "companyRequired": true, "funding": "Early-stage company capital (deal-specific)", "caveats": [ "This is company-building support, not an academic pilot grant." ], "investigatorReturns": [ "company infrastructure and talent", "early capital", "regional investor network" ], "nextStates": [ "s8", "s9" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://www.biostl.org/what-we-do/biogenerator", "https://www.biostl.org/about/" ] }, { "id": "nih-ninds-sbir", "type": "resource", "title": "NIH SBIR/STTR small-business funding", "organization": "NIH SEED", "url": "https://seed.nih.gov/small-business-funding/find-funding/sbir-sttr-funding-opportunities", "internality": "federal", "needs": [ "funding" ], "inventionTypes": [ "broad" ], "locations": [ "national" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "research-tool" ], "states": [ "s6", "s7", "s8", "s9" ], "problemsSolved": [ "funding", "small-business" ], "whatYouGet": "NIH SBIR/STTR funding for eligible U.S. small businesses conducting biomedical R&D. The program can support scientists, engineers, prototypes, validation, and commercialization-oriented research while preserving equity; institute-specific scientific fit still matters.", "whyYouMightCare": "A major non-dilutive funding route once product-oriented biomedical R&D belongs inside an eligible U.S. small business. Keep this card broad; use institute-specific cards such as NINDS Translational Devices when the modality and disease area justify them.", "usefulWhen": [ "A biomedical product-oriented project has a credible small-business path", "A company needs non-dilutive R&D funding before or alongside private capital", "You need to distinguish SBIR/STTR from academic-only grant mechanisms" ], "notFor": [ "An academic laboratory acting alone; the applicant must be an eligible U.S. small business", "Assume this replaces institute-specific scientific fit or current NOFO review" ], "eligibility": "SBIR/STTR applicant must meet U.S. small-business eligibility. Universities may participate as research partners/subawardees; STTR has formal research-institution participation requirements. Confirm current NIH and institute-specific rules before submission.", "requiresDisclosure": false, "companyRequired": true, "funding": "NIH SBIR/STTR (verify current NOFO and institute fit)", "caveats": [ "An academic lab alone is not an SBIR/STTR applicant.", "Use the separate NINDS Translational Devices card for nervous-system therapeutic/diagnostic device programs and Missouri SBDC for local proposal assistance.", "I-Corps at NIH is generally downstream of a qualifying Phase I award — not an entry program." ], "investigatorReturns": [ "substantial non-dilutive company R&D funding", "funded technical and translational milestones", "a bridge to later validation and commercialization work" ], "nextStates": [ "s7", "s8", "s9" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://seed.nih.gov/small-business-funding/find-funding/sbir-sttr-funding-opportunities" ] }, { "id": "washu-innovation", "type": "resource", "title": "WashU Innovation", "organization": "Washington University in St. Louis", "url": "https://innovation.wustl.edu/", "internality": "washu", "needs": [ "expertise-mentorship" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "research-tool" ], "states": [ "s0", "s1" ], "problemsSolved": [ "orientation", "discovery" ], "whatYouGet": "University-wide roadmap and directory spanning commercialization, education, funding, and space. WashU describes its process as Identify → Evaluate → Connect → Support → Communicate.", "whyYouMightCare": "Useful when you do not yet know which part of the university ecosystem is for you. No company or disclosure is required merely to explore.", "usefulWhen": [ "You do not know where in the university ecosystem you belong", "You want an institutional map before a specific program" ], "notFor": [ "Investigator-specific eligibility or a next experiment", "A substitute for OTM, ICTS, or a modality-specific program" ], "eligibility": "General WashU ecosystem resource.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "This is orientation. Route onward into OTM, funding, or a translational program." ], "investigatorReturns": [ "orientation", "discovery of the right door" ], "nextStates": [ "s1", "s3" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://innovation.wustl.edu/", "https://innovation.wustl.edu/our-process/", "https://innovation.wustl.edu/our-ecosystem/" ], "priority": "second", "purposes": [ "research" ] }, { "id": "quick-start-license", "type": "resource", "title": "OTM Quick Start License", "organization": "Office of Technology Management, WashU", "url": "https://otm.wustl.edu/disclose-inventions/quick-start-license/", "internality": "washu", "needs": [ "ip-licensing", "startup-support" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "therapeutic", "device", "diagnostic", "software" ], "states": [ "s8" ], "problemsSolved": [ "license", "startup" ], "whatYouGet": "A standardized startup license. Current public terms include no WashU equity and a fixed 2% patent royalty on product sales, with additional sublicense terms.", "whyYouMightCare": "Can simplify license formation once a WashU-IP startup is actually the vehicle — not a reason to create one.", "usefulWhen": [ "A qualifying WashU-IP startup is ready to license foundational university patent rights", "Standardized terms could reduce negotiation burden" ], "notFor": [ "Investigators who want to license to an existing company rather than found", "An early idea with no company hypothesis" ], "eligibility": "Qualifying startup and IP conditions apply. Contact OTM before assuming eligibility.", "requiresDisclosure": true, "companyRequired": true, "funding": null, "caveats": [ "This is a vehicle after startup direction is credible, not a reason to incorporate." ], "investigatorReturns": [ "a simpler license path once founding is justified" ], "nextStates": [ "s8", "s9" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://otm.wustl.edu/disclose-inventions/quick-start-license/" ], "contact": "OTM New Ventures · otm@wustl.edu", "priority": "second", "purposes": [ "ip", "company" ] }, { "id": "skandalaris-ideabounce", "type": "resource", "title": "Skandalaris In-Residence / IdeaBounce", "organization": "Skandalaris Center, WashU", "url": "https://skandalaris.wustl.edu/programs/", "internality": "washu", "needs": [ "expertise-mentorship", "industry-connections" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "device", "software", "research-tool", "therapeutic", "diagnostic" ], "states": [ "s4", "s6", "s8" ], "problemsSolved": [ "feedback", "networking", "venture-exploration" ], "whatYouGet": "Experienced entrepreneur and industry perspectives. IdeaBounce provides pitching, feedback, and networking.", "whyYouMightCare": "Useful before committing to a venture. You do not need a finished company or investor deck.", "usefulWhen": [ "You want founder or industry feedback on how an idea is communicated", "You want a low-stakes venue before venture commitment" ], "notFor": [ "A WashU-IP faculty invention seeking the Venture Competition awards", "A substitute for OTM evaluation" ], "eligibility": "Skandalaris services broadly include WashU faculty, staff, students, and alumni; individual event requirements vary.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "Do not confuse this with the Skandalaris Venture Competition." ], "investigatorReturns": [ "early feedback", "network without a finished deck" ], "nextStates": [ "s6", "s8" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://skandalaris.wustl.edu/programs/" ], "contact": "sc@wustl.edu", "priority": "second", "purposes": [ "expertise", "company" ] }, { "id": "skandalaris-svc", "type": "resource", "title": "Skandalaris Venture Competition (SVC)", "organization": "Skandalaris Center, WashU", "url": "https://skandalaris.wustl.edu/program/skandalaris-venture-competition/", "internality": "washu", "needs": [ "funding", "startup-support" ], "inventionTypes": [ "broad" ], "locations": [ "washu" ], "domains": [ "device", "software", "research-tool", "therapeutic", "diagnostic" ], "states": [ "s8" ], "problemsSolved": [ "startup", "competition" ], "whatYouGet": "Competition awards. Fall 2026 materials describe an awards pool of up to $25,000, subject to limits per startup.", "whyYouMightCare": "Can provide venture validation and money for an eligible student or recent-alumni venture that does not rely on university IP. It should normally be suppressed for a faculty WashU-IP invention.", "usefulWhen": [ "An eligible student or recent-alumni venture does not rely on university IP" ], "notFor": [ "Faculty inventions that are WashU IP", "Any startup whose license is to WashU or another university’s IP" ], "eligibility": "Qualifying WashU student or recent alum and ownership rules apply. WashU IP is not permitted, nor is a license to IP from WashU or another university.", "requiresDisclosure": false, "companyRequired": true, "funding": "Awards pool up to $25,000 (verify current cycle)", "caveats": [ "Critical trap: current rules prohibit WashU / university IP and licenses to university IP." ], "investigatorReturns": [ "venture validation — only if you are actually eligible" ], "nextStates": [ "s8" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://skandalaris.wustl.edu/program/skandalaris-venture-competition/" ], "contact": "sc@wustl.edu", "priority": "second", "purposes": [ "company", "funding" ] }, { "id": "veritascience", "type": "resource", "title": "VeritaScience — WashU + Deerfield", "organization": "Washington University in St. Louis · Deerfield Management", "url": "https://source.wustl.edu/2024/01/washington-university-deerfield-management-launch-veritascience-to-drive-drug-discovery/", "internality": "washu", "needs": [ "funding", "expertise-mentorship" ], "inventionTypes": [ "therapeutics" ], "locations": [ "washu" ], "domains": [ "therapeutic", "diagnostic" ], "states": [ "s5", "s6", "s7" ], "problemsSolved": [ "therapeutic-development", "funding", "ind" ], "whatYouGet": "Deerfield committed up to $130 million over ten years. Accepted drug-discovery projects receive development plans aimed toward IND readiness and may receive further funding or support, including possible company formation.", "whyYouMightCare": "Industry drug-development expertise and capital without requiring a pre-existing startup.", "usefulWhen": [ "A therapeutic or diagnostic discovery needs a milestone-driven development plan", "You need specialized industry capabilities and substantial development capital" ], "notFor": [ "Non-drug devices or research tools", "A general faculty grant program" ], "eligibility": "WashU investigator proposals; disease indication may vary. Current standing submission dates are unspecified publicly in the source reviewed.", "requiresDisclosure": false, "companyRequired": false, "funding": "Up to $130M over ten years across the collaboration (project-specific)", "caveats": [ "Routing is through WashU/Deerfield scientific review, guided by OTM and WUSM business development.", "Older information-session contact should be verified before use." ], "investigatorReturns": [ "industry development expertise", "IND-oriented planning", "possible later company support" ], "nextStates": [ "s7", "s8" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://source.wustl.edu/2024/01/washington-university-deerfield-management-launch-veritascience-to-drive-drug-discovery/" ], "contact": "OTM / WUSM business development; verify current contact", "priority": "second", "purposes": [ "funding", "expertise" ] }, { "id": "bms-neuro", "type": "resource", "title": "Bristol Myers Squibb–WashU neuroscience collaboration", "organization": "Washington University School of Medicine · BMS", "url": "https://medicine.wustl.edu/news/washu-announces-new-academic-industry-collaboration-with-bristol-myers-squibb/", "internality": "washu", "needs": [ "funding", "industry-connections" ], "inventionTypes": [ "therapeutics" ], "locations": [ "washu" ], "domains": [ "therapeutic" ], "states": [ "s4", "s6", "s7" ], "problemsSolved": [ "collaboration", "trainees", "therapeutic-development" ], "whatYouGet": "Multiyear collaboration funding up to three translational neuroscience research programs per year and up to three visiting fellows per year, working alongside BMS scientists.", "whyYouMightCare": "Collaboration, translational expertise, and trainee industry exposure without startup formation. Industry collaboration is itself an academic return.", "usefulWhen": [ "A neuroscience therapeutic program would benefit from pharmaceutical-development engagement", "A trainee would benefit from a visiting-fellow placement" ], "notFor": [ "Non-neuroscience projects outside the stated priority areas", "A general startup accelerator" ], "eligibility": "Priority areas include neurological, neuromuscular, neuroinflammatory, and psychiatric conditions. The first announced EOI deadline was September 1, 2026 and has passed; monitor future rounds.", "requiresDisclosure": false, "companyRequired": false, "funding": "Up to three translational programs and three visiting fellows per year", "caveats": [ "The first EOI window has passed as of 2026-09-04. Treat this as a future cycle until a new call opens." ], "investigatorReturns": [ "industry collaborators", "trainee placements", "drug-development exposure without founding" ], "nextStates": [ "s6", "s7" ], "status": "closed_verify", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://medicine.wustl.edu/news/washu-announces-new-academic-industry-collaboration-with-bristol-myers-squibb/" ], "contact": "Mark Van Horn · markv@wustl.edu", "priority": "second", "purposes": [ "research", "funding", "expertise" ] }, { "id": "neuro360", "type": "resource", "title": "NEURO360 / regional neuroscience innovation network", "organization": "Washington University in St. Louis · regional partners", "url": "https://innovation.wustl.edu/our-ecosystem/", "internality": "regional", "needs": [ "industry-connections" ], "inventionTypes": [ "therapeutics", "devices-diagnostics", "research-tools" ], "locations": [ "regional" ], "domains": [ "device", "therapeutic", "research-tool" ], "states": [ "s4", "s8" ], "problemsSolved": [ "network", "ecosystem" ], "whatYouGet": "A WashU-led regional neuroscience innovation effort originally supported through an NSF Engines Development Award and involving regional organizations including BioSTL.", "whyYouMightCare": "A network layer connecting academic neuroscience to regional company-building and workforce resources — not a guaranteed individual grant.", "usefulWhen": [ "The opportunity needs regional neuroscience-industry connections or cluster-scale visibility" ], "notFor": [ "A standing individual-investigator application you can submit this week" ], "eligibility": "A standing individual-investigator application route is not publicly specified. Model this as an ecosystem/network node rather than guaranteed funding.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "Program status should be periodically re-verified. Do not treat this as a walk-in funding call." ], "investigatorReturns": [ "regional visibility", "industry network" ], "nextStates": [ "s8" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://innovation.wustl.edu/our-ecosystem/" ], "priority": "second", "purposes": [ "expertise", "company" ] }, { "id": "biogenerator-connect", "type": "resource", "title": "BioGenerator Startup Connect", "organization": "BioGenerator Ventures", "url": "https://www.biostl.org/what-we-do/biogenerator", "internality": "regional", "needs": [ "industry-connections" ], "inventionTypes": [ "therapeutics", "devices-diagnostics", "research-tools" ], "locations": [ "st-louis" ], "domains": [ "therapeutic", "device", "diagnostic", "research-tool" ], "states": [ "s8", "s9" ], "problemsSolved": [ "investors", "networking" ], "whatYouGet": "Invite-only presentations, investor meetings, and networking among human-health and agriculture startups, investors, academics, government, and corporate partners.", "whyYouMightCare": "Investor exposure without relying only on cold outreach — once a company is real enough to present.", "usefulWhen": [ "A startup is mature enough to benefit from curated investor meetings" ], "notFor": [ "An early idea-development program", "An academic project with no company" ], "eligibility": "Invite-only. Not an early idea-development program.", "requiresDisclosure": false, "companyRequired": true, "funding": null, "caveats": [ "Current noted event: September 9–10, 2026. Confirm before planning around it." ], "investigatorReturns": [ "investor meetings", "ecosystem visibility" ], "nextStates": [ "s9" ], "status": "evergreen_program_verify_current_call", "nextDeadline": "2026-09-09 (Startup Connect; verify)", "lastVerified": "2026-09-06", "sourceUrls": [ "https://www.biostl.org/what-we-do/biogenerator" ], "contact": "aj@biogeneratorventures.com", "priority": "second", "purposes": [ "company" ] }, { "id": "cortex-ignite", "type": "resource", "title": "Cortex SQ1 Ignite / Bootcamp", "organization": "Cortex Innovation Community", "url": "https://www.cortexstl.org/learn/entrepreneur-training/sq1-ignite", "internality": "regional", "needs": [ "startup-support", "expertise-mentorship" ], "inventionTypes": [ "broad" ], "locations": [ "st-louis" ], "domains": [ "device", "software", "research-tool", "therapeutic", "diagnostic" ], "states": [ "s4", "s6", "s8" ], "problemsSolved": [ "venture-exploration", "customer-discovery", "education" ], "whatYouGet": "Ignite is a four-week concept-stage program using business-model validation, mentors, and ecosystem connections. Bootcamp is a more intensive ten-week / 50-hour program.", "whyYouMightCare": "A low-cost way to test entrepreneurial assumptions. You do not need an investor-ready company to enter Ignite.", "usefulWhen": [ "You want structured entrepreneurship or customer-discovery education", "You are testing whether a venture is even sensible" ], "notFor": [ "A substitute for OTM on a WashU invention", "Late-stage company financing" ], "eligibility": "Ignite prerequisites are light. Current listed fee is $50 with need-based scholarships. Cohort dates vary.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "Education, not capital. Confirm current cohort dates." ], "investigatorReturns": [ "customer-discovery practice", "a low-stakes read on founding" ], "nextStates": [ "s6", "s8" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://www.cortexstl.org/learn/entrepreneur-training/sq1-ignite" ], "contact": "info@cortexstl.org", "priority": "second", "purposes": [ "expertise", "company" ] }, { "id": "arch-grants", "type": "resource", "title": "Arch Grants Startup Competition", "organization": "Arch Grants", "url": "https://archgrants.org/programs/startup-competition/", "internality": "regional", "needs": [ "funding", "startup-support" ], "inventionTypes": [ "broad" ], "locations": [ "st-louis" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "research-tool" ], "states": [ "s8", "s9" ], "problemsSolved": [ "funding", "startup" ], "whatYouGet": "$75,000 equity-free; an additional $25,000 for qualifying relocations; eligibility for follow-on Growth Grants up to $100,000; fundraising and network support.", "whyYouMightCare": "Non-dilutive startup capital — if the company can actually meet the founder and St. Louis commitments.", "usefulWhen": [ "A genuine startup can commit to building in St. Louis", "Founders want equity-free company capital" ], "notFor": [ "An academic laboratory project", "A faculty side project without a full-time founder" ], "eligibility": "Company headquarters in St. Louis for at least one year; residency and team requirements; at least one founder must currently work on the company as their primary/full-time role. 2026 applications are closed.", "requiresDisclosure": false, "companyRequired": true, "funding": "$75,000 equity-free (+ $25,000 relocation; Growth Grants up to $100,000)", "caveats": [ "2026 applications are closed. Headquarters and full-time founder requirements are hard gates." ], "investigatorReturns": [ "equity-free company capital — if eligible" ], "nextStates": [ "s9" ], "status": "closed_verify", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://archgrants.org/programs/startup-competition/" ], "contact": "competition@archgrants.org", "priority": "second", "purposes": [ "funding", "company" ] }, { "id": "mtc-idea", "type": "resource", "title": "Missouri Technology Corporation IDEA Fund", "organization": "Missouri Technology Corporation", "url": "https://www.missouritechnology.com/venture-capital-investments/mtc-idea-fund/", "internality": "regional", "needs": [ "funding" ], "inventionTypes": [ "broad" ], "locations": [ "regional" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "research-tool" ], "states": [ "s8", "s9" ], "problemsSolved": [ "funding", "startup" ], "whatYouGet": "Current tracks include TechLaunch (up to $250,000 for companies raising under $1M), Seed Capital (up to $1M for $1–5M raises), and a larger venture track. MTC investments require private matching capital.", "whyYouMightCare": "Can leverage an external financing round with state-backed investment. This is equity, not an academic grant.", "usefulWhen": [ "A Missouri technology startup is raising an institutional pre-seed, seed, or Series A round", "The company can attract matching private capital" ], "notFor": [ "An academic grant or proof-of-concept pilot (that earlier pilot is currently paused)", "A laboratory without a company" ], "eligibility": "Missouri location and growth requirements, plus matching co-investment. The earlier proof-of-concept pilot is currently paused.", "requiresDisclosure": false, "companyRequired": true, "funding": "Equity investment with private match (track-specific; verify)", "caveats": [ "This is matching equity investment, not a faculty grant." ], "investigatorReturns": [ "state-backed match on a real financing round" ], "nextStates": [ "s9" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://www.missouritechnology.com/venture-capital-investments/mtc-idea-fund/" ], "priority": "second", "purposes": [ "funding", "company" ] }, { "id": "missouri-sbdc", "type": "resource", "title": "Missouri SBDC FAST / SBIR-STTR assistance", "organization": "Missouri Small Business Development Center", "url": "https://sbdc.missouri.edu/programs/technology/funding", "internality": "regional", "needs": [ "expertise-mentorship" ], "inventionTypes": [ "broad" ], "locations": [ "regional" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "research-tool" ], "states": [ "s6", "s7", "s8" ], "problemsSolved": [ "funding", "small-business" ], "whatYouGet": "Resources, expertise, and assistance navigating SBIR/STTR proposal strategy and submission.", "whyYouMightCare": "Useful when you understand the science but not the federal small-business process. No venture-capital raise is required to seek advising.", "usefulWhen": [ "A founder is considering federal SBIR/STTR", "The team needs proposal strategy or submission support" ], "notFor": [ "An academic laboratory that will not form or partner with a small business" ], "eligibility": "Targeted to small businesses and prospective SBIR/STTR applicants. Current grants and services vary by FAST cycle.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "Advising is not an award. The applicant still must be an eligible small business." ], "investigatorReturns": [ "proposal strategy", "local SBIR/STTR navigation" ], "nextStates": [ "s8" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://sbdc.missouri.edu/programs/technology/funding" ], "priority": "second", "purposes": [ "expertise", "funding" ] }, { "id": "cultivation-capital", "type": "resource", "title": "Cultivation Capital — Life Sciences & Health Tech", "organization": "Cultivation Capital", "url": "https://cultivationcapital.com/strategies/life-sciences-health-technology/", "internality": "investor", "needs": [ "funding" ], "inventionTypes": [ "therapeutics", "devices-diagnostics", "research-tools" ], "locations": [ "st-louis" ], "domains": [ "therapeutic", "device", "diagnostic", "research-tool" ], "states": [ "s8", "s9" ], "problemsSolved": [ "funding", "startup" ], "whatYouGet": "St. Louis-based venture capital. Current site describes initial checks roughly $100,000–$3.5 million and investing from seed through Series B.", "whyYouMightCare": "Regional capital plus investor perspective — once there is an investable company, not a grant application.", "usefulWhen": [ "A startup has a credible financing proposition in therapeutics, diagnostics, tools, devices, or health technology" ], "notFor": [ "A faculty grant", "An idea without a company" ], "eligibility": "Requires an investable company. No standardized investigator eligibility. Not a grant.", "requiresDisclosure": false, "companyRequired": true, "funding": "Venture investment, roughly $100k–$3.5M initial checks (verify)", "caveats": [ "Downstream financing. Not a general investigator service." ], "investigatorReturns": [ "regional venture capital — if the company is investable" ], "nextStates": [ "s9" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://cultivationcapital.com/strategies/life-sciences-health-technology/" ], "priority": "second", "purposes": [ "company", "funding" ] }, { "id": "rivervest", "type": "resource", "title": "RiverVest Venture Partners", "organization": "RiverVest", "url": "https://rivervest.com/", "internality": "investor", "needs": [ "funding", "startup-support" ], "inventionTypes": [ "therapeutics", "devices-diagnostics" ], "locations": [ "st-louis" ], "domains": [ "therapeutic", "device" ], "states": [ "s8", "s9" ], "problemsSolved": [ "funding", "startup" ], "whatYouGet": "St. Louis-headquartered life-science VC that funds and founds biopharma and device companies and can lead financing syndicates.", "whyYouMightCare": "Relevant when the question has moved from “is there a product?” to “is this a venture-scale company?”", "usefulWhen": [ "A biopharma or medical-device company needs sophisticated company formation or venture financing" ], "notFor": [ "Academic projects", "Pre-company de-risking" ], "eligibility": "Company and investment diligence required; terms are opportunity-specific.", "requiresDisclosure": false, "companyRequired": true, "funding": "Venture financing (deal-specific)", "caveats": [ "Downstream financing. Not a faculty program." ], "investigatorReturns": [ "venture-scale company formation and capital" ], "nextStates": [ "s9" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://rivervest.com/" ], "contact": "info@rivervest.com · 314-726-6700", "priority": "second", "purposes": [ "company", "funding" ] }, { "id": "oup", "type": "resource", "title": "Osage University Partners (OUP)", "organization": "Osage University Partners", "url": "https://oup.vc/", "internality": "investor", "needs": [ "funding" ], "inventionTypes": [ "therapeutics", "devices-diagnostics", "research-tools" ], "locations": [ "national" ], "domains": [ "therapeutic", "device", "diagnostic", "research-tool" ], "states": [ "s8", "s9" ], "problemsSolved": [ "funding", "startup" ], "whatYouGet": "VC focused on science-driven startups from research ecosystems. Current sectors include therapeutics, medtech, diagnostics, and research tools. Current site states $1M–$20M investment size across stages.", "whyYouMightCare": "An investor familiar with university technology-transfer and spinout issues.", "usefulWhen": [ "University-originated science has venture-scale potential", "The company needs investors who understand academic IP" ], "notFor": [ "A grant or general faculty assistance program" ], "eligibility": "Investment opportunity required. No grant program.", "requiresDisclosure": false, "companyRequired": true, "funding": "Venture investment, $1M–$20M across stages (verify)", "caveats": [ "Downstream financing. Not an investigator service." ], "investigatorReturns": [ "university-spinout-fluent capital" ], "nextStates": [ "s9" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://oup.vc/" ], "priority": "second", "purposes": [ "company", "funding" ] }, { "id": "nih-icorps", "type": "resource", "title": "I-Corps at NIH", "organization": "NIH SEED", "url": "https://seed.nih.gov/I-Corps-at-NIH", "internality": "federal", "needs": [ "expertise-mentorship", "startup-support" ], "inventionTypes": [ "broad" ], "locations": [ "national" ], "domains": [ "therapeutic", "device", "diagnostic", "software", "research-tool" ], "states": [ "s8" ], "problemsSolved": [ "customer-discovery", "education" ], "whatYouGet": "Structured commercialization and customer-discovery program. NIH SEED describes a three-person team model and program support.", "whyYouMightCare": "Excellent after technical feasibility when product and customer assumptions are still uncertain — and only after a qualifying Phase I award.", "usefulWhen": [ "An NIH-funded Phase I small business needs intensive customer discovery" ], "notFor": [ "An unfunded academic idea", "An entry customer-discovery program for faculty without a Phase I award" ], "eligibility": "Generally requires an eligible recent or active NIH/CDC/FDA/ACL Phase I SBIR/STTR award and no Phase II award yet.", "requiresDisclosure": false, "companyRequired": true, "funding": null, "caveats": [ "Not an entry program for an unfunded academic idea. Downstream of a qualifying Phase I award." ], "investigatorReturns": [ "customer discovery after Phase I" ], "nextStates": [ "s8", "s9" ], "status": "evergreen", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://seed.nih.gov/I-Corps-at-NIH" ], "priority": "second", "purposes": [ "expertise", "company" ] }, { "id": "ncats-sbir", "type": "resource", "title": "NCATS Small Business Programs", "organization": "National Center for Advancing Translational Sciences", "url": "https://ncats.nih.gov/funding/small-business-programs/resources-applicants", "internality": "federal", "needs": [ "funding" ], "inventionTypes": [ "broad" ], "locations": [ "national" ], "domains": [ "therapeutic", "device", "diagnostic", "research-tool", "software" ], "states": [ "s6", "s7", "s8" ], "problemsSolved": [ "funding", "small-business" ], "whatYouGet": "SBIR/STTR funding and program guidance aligned with translational science. NCATS encourages prospective applicants to discuss program fit.", "whyYouMightCare": "Useful for platforms or tools that may not fit a single disease-oriented institute cleanly.", "usefulWhen": [ "The technology addresses a translational-science bottleneck or broadly enabling biomedical need", "A company is being considered" ], "notFor": [ "An academic lab acting alone" ], "eligibility": "NIH small-business eligibility applies to SBIR/STTR.", "requiresDisclosure": false, "companyRequired": true, "funding": "NIH SBIR/STTR (verify current NOFO)", "caveats": [ "Discuss fit with NCATS before treating this as a default institute." ], "investigatorReturns": [ "non-dilutive funding for enabling platforms" ], "nextStates": [ "s8" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://ncats.nih.gov/funding/small-business-programs/resources-applicants" ], "contact": "NCATS-SBIRSTTR@mail.nih.gov", "priority": "second", "purposes": [ "funding", "company" ] }, { "id": "ninds-devices", "type": "resource", "title": "NINDS Translational Devices + Small Business Program", "organization": "National Institute of Neurological Disorders and Stroke", "url": "https://www.ninds.nih.gov/current-research/research-funded-ninds/translational-research/translational-devices", "internality": "federal", "needs": [ "funding" ], "inventionTypes": [ "devices-diagnostics" ], "locations": [ "national" ], "domains": [ "device", "diagnostic" ], "states": [ "s6", "s7", "s8" ], "problemsSolved": [ "device-translation", "funding" ], "whatYouGet": "Support for development, optimization, translation, and first-in-human testing of therapeutic and diagnostic devices. NINDS also has dedicated small-business programs.", "whyYouMightCare": "A neuroscience-specific route that can finance evidence R01-style projects often do not emphasize.", "usefulWhen": [ "A device or neurotechnology addresses a nervous-system disorder", "You need milestone-driven translation, regulatory preparation, or first-in-human work" ], "notFor": [ "A generic assumption that every NINDS device NOFO is academic — some are small-business-only" ], "eligibility": "Depends on the specific NOFO. Some routes are academic; others are small-business-only. Inspect the current announcement.", "requiresDisclosure": false, "companyRequired": false, "funding": "NINDS translational-device and small-business NOFOs (verify current)", "caveats": [ "Do not infer eligibility from the program family. Read the current NOFO." ], "investigatorReturns": [ "device-translation milestones", "possible first-in-human support" ], "nextStates": [ "s7", "s8" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://www.ninds.nih.gov/current-research/research-funded-ninds/translational-research/translational-devices", "https://www.ninds.nih.gov/funding/ninds-small-business-program" ], "priority": "second", "purposes": [ "funding", "research" ] }, { "id": "nia-sbir", "type": "resource", "title": "NIA Small Business — Alzheimer’s / ADRD and aging", "organization": "National Institute on Aging", "url": "https://www.nia.nih.gov/research/sbir/about-nia-small-business-funding", "internality": "federal", "needs": [ "funding" ], "inventionTypes": [ "therapeutics", "devices-diagnostics", "research-tools" ], "locations": [ "national" ], "domains": [ "therapeutic", "device", "diagnostic", "research-tool" ], "states": [ "s6", "s7", "s8" ], "problemsSolved": [ "funding", "small-business" ], "whatYouGet": "A dedicated SBIR/STTR program. NIA reports more than $140M/year in small-business support across aging and AD/ADRD areas.", "whyYouMightCare": "Neuroscience-specific non-dilutive capital for one of WashU’s major strengths — if a small-business path is real.", "usefulWhen": [ "An Alzheimer’s, ADRD, or aging-related diagnostic, tool, therapeutic, or service has a plausible small-business path" ], "notFor": [ "An academic lab acting alone" ], "eligibility": "Small-business program requirements apply. Specific NOFO deadlines and areas should be queried live.", "requiresDisclosure": false, "companyRequired": true, "funding": "NIA SBIR/STTR (verify current)", "caveats": [ "Company eligibility applies. Confirm current NOFO areas." ], "investigatorReturns": [ "disease-specific non-dilutive R&D funding" ], "nextStates": [ "s8" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://www.nia.nih.gov/research/sbir/about-nia-small-business-funding" ], "priority": "second", "purposes": [ "funding", "company" ] }, { "id": "nsf-icorps", "type": "resource", "title": "NSF I-Corps", "organization": "National Science Foundation", "url": "https://www.nsf.gov/funding/initiatives/i-corps", "internality": "federal", "needs": [ "expertise-mentorship", "startup-support" ], "inventionTypes": [ "devices-diagnostics", "software-digital", "research-tools" ], "locations": [ "national" ], "domains": [ "device", "software", "research-tool", "algorithm" ], "states": [ "s4", "s6", "s8" ], "problemsSolved": [ "customer-discovery", "education" ], "whatYouGet": "National I-Corps teams combine technical, entrepreneurial, and industry perspectives around customer discovery.", "whyYouMightCare": "Useful for instrumentation, engineering, computation, and research tools where clinical-disease programs are a poor fit.", "usefulWhen": [ "A deep-tech or scientific invention needs systematic customer discovery", "NSF’s commercialization ecosystem fits better than NIH" ], "notFor": [ "An assumption that every WashU invention qualifies", "A substitute for OTM on university IP" ], "eligibility": "Current team and award eligibility depends on the NSF route. Do not assume every WashU invention qualifies.", "requiresDisclosure": false, "companyRequired": false, "funding": null, "caveats": [ "Eligibility is route-specific. Confirm before planning around a cohort." ], "investigatorReturns": [ "customer discovery for non-clinical deep tech" ], "nextStates": [ "s6", "s8" ], "status": "evergreen_program_verify_current_call", "nextDeadline": null, "lastVerified": "2026-09-06", "sourceUrls": [ "https://www.nsf.gov/funding/initiatives/i-corps" ], "priority": "second", "purposes": [ "expertise", "company" ] } ] }